Skip to main content

Peer Review reports

From: PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study

Original Submission
17 Sep 2021 Submitted Original manuscript
25 Sep 2021 Reviewed Reviewer Report
5 Oct 2021 Reviewed Reviewer Report
2 Nov 2021 Author responded Author comments - Mingtong Xu
Resubmission - Version 2
2 Nov 2021 Submitted Manuscript version 2
3 Nov 2021 Reviewed Reviewer Report
16 Nov 2021 Reviewed Reviewer Report
25 Nov 2021 Author responded Author comments - Mingtong Xu
Resubmission - Version 3
25 Nov 2021 Submitted Manuscript version 3
Publishing
6 Dec 2021 Editorially accepted
18 Jan 2022 Article published 10.1186/s12916-021-02208-w

You can find further information about peer review here.

Back to article page